{"id":"W4387462087","doi":"10.1016/j.cardfail.2023.09.002","title":"Safety Indicators in Patients Receiving High-intensity Care After Hospital Admission for Acute Heart Failure: The STRONG-HF Trial","year":2023,"lang":"en","type":"article","venue":"Journal of Cardiac Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"ca_institutions":"Surgical Specialties (Canada)","funders":"Medical Research Council; Servier; Novo Nordisk; National Medical Research Council; Cytokinetics; Strong; Vifor Pharma; Pfizer; LivaNova; Amgen; Edwards Lifesciences; Alnylam Pharmaceuticals; Sanofi; American Heart Association; Abbott Vascular; Abbott Laboratories; AstraZeneca","keywords":"Medicine; Heart failure; Hazard ratio; Tolerability; Confidence interval; Natriuretic peptide; Internal medicine; Renal function; Guideline; Cardiology; Adverse effect; Heart rate; Blood pressure","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003790809,0.000734062,0.001342323,0.0001798854,0.0002695036,0.0008704417,0.0004148985,0.00103855,0.002179492],"category_scores_gemma":[0.00433788,0.0001990075,0.001616823,0.0003226877,0.0004470235,0.0007011784,0.0005871259,0.001604841,0.0001843951],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003824798,"about_ca_system_score_gemma":0.000621972,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006066854,"about_ca_topic_score_gemma":0.001110008,"domain_scores_codex":[0.9982039,0.001240373,0.0001564719,0.0001303449,0.0001026452,0.0001662501],"domain_scores_gemma":[0.9974094,0.0008544911,0.0009179958,0.0002349355,0.000122262,0.000460857],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8192884,0.005464564,0.1066619,0.001730407,0.008157507,0.00007870232,0.0001223503,0.001362168,0.001268639,0.0005587825,0.004790434,0.05051609],"study_design_scores_gemma":[0.4979204,0.1109087,0.3708683,0.000766243,0.009824443,0.0001373848,0.0002208302,0.00296663,0.001061519,0.001510189,0.003705062,0.0001103527],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9920714,0.004301785,0.0002373767,0.0008952934,0.0002008903,0.000265531,0.0006415965,0.00002379418,0.001362258],"genre_scores_gemma":[0.9961069,0.0009175922,0.0003580597,0.0007653788,0.0002625643,0.0003218537,0.0009399213,0.000004708083,0.0003230055],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003790809,"threshold_uncertainty_score":0.02004796,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.006357610077282144,"score_gpt":0.2608015017056808,"score_spread":0.2544438916283986,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}